(10)Fmoc-Gly-Lys(Boc)-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin (10) Preparation of Fmoc-Gly-Lys(Boc)-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin (9)Fmoc-Lys(Boc)-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin(20DMF)5203DMF3DMF2Fmoc-Gly-OH0.7gDIEA0.4mlTBTU0.56gHOBT0.2gDMF10ml1.53DMF3DMF2Fmoc-Gly-Lys(Boc)-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin In the Fmoc-Lys(Boc)-Pro-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-WangResin in step (9), add a decapping reagent (20% piperidine in DMF) , reacted at room temperature for 5 minutes, drained, added decapping agent and reacted at room temperature for 20 minutes, washed 3 times with isopropanol, washed 3 times with DMF, washed 2 times with distilled DMF, drained, added Fmoc-Gly-OH0
The timing of dox or cisplatin treatment is indicated as Day 0 by a dark blue line, with lighter dashed lines for subsequent 50-day increments
National Center for Complementary and Integrative Health (NCCIH)
SmithCEParnellLDLaiCQRushJEAdinDBOrdovsJMet al
In absolute terms, this means success rates of around 15-20% at one year with NRT versus 3-6% without any support
doi: 10.1016/j.yfrne.2019.100788 122 BoghozianRMcKenzieBASaitoLBMehtaNBrantonWGLuJet al
